• Use of hepatobiliary contrast agents (such as Eovist), which are normally secreted into bile, may be helpful
Lack of filling or delayed filling (> 60 minutes) of GB supports diagnosis of acute cholecystitis
Normal filling (< 60 minutes) does not exclude cholecystitis
GB usually fills with contrast in chronic cholecystitis
Ultrasonographic Findings
• Grayscale ultrasound
Uncomplicated cholecystitis
– Cholelithiasis (usually an immobile, impacted stone in GB neck or cystic duct), sonographic Murphy sign, and GB wall thickening > 3 mm
– GB distension > 5 cm in short axis
– Increased vascularity of GB wall on color Doppler images
Complicated cholecystitis
– Perforated cholecystitis: Pericholecystic abscess with collapsed GB
High-frequency transducer may allow better visualization of GB fundus to help exclude early perforation
Sonographic hole sign: Visualization of GB wall defect on US
– Gangrenous cholecystitis: Asymmetric wall thickening, intraluminal linear membranes, and irregularity and ulcerations of GB wall
Striated GB, contrary to prior teaching, not convincingly associated with gangrene
GB wall hyperemia may be absent on color Doppler images as result of wall necrosis
– Emphysematous cholecystitis: Gas in GB lumen and wall (brightly echogenic reflectors with dense “dirty” posterior acoustic shadowing)
GB itself may be difficult to visualize as result of shadowing from gas
– Hemorrhagic cholecystitis: Echogenic clot within GB lumen or visualized biliary tree
• Color Doppler
Increased vascularity of GB wall (flow may be absent in gangrenous cholecystitis)
Nuclear Medicine Findings
• Hepatobiliary scintigraphy
Tc-99m iminodiacetic acid derivatives
Nonvisualization of GB 4 hours after radiotracer injection (or 30 minutes after morphine administration)
Increased uptake in GB fossa (rim sign) due to hyperemia in 35% of patients
– Very specific (but not sensitive) for acute cholecystitis
– Positive predictive value of 57% for gangrenous cholecystitis
Hepatobiliary scintigraphy more sensitive (97%) and specific (90%) compared to US (88% and 80%, respectively)
False-positive results in patients who have recently eaten, undergone prolonged fasting (> 24 hours), received hyperalimentation, have severe concurrent illness, or who have severe hepatocellular dysfunction
Imaging Recommendations
• Best imaging tool
US is best screening tool
Hepatobiliary scintigraphy for confirmation (particularly when US is equivocal)
CECT to evaluate potential complications
• Protocol advice
Measure GB wall thickness adjacent to liver
Move patient during ultrasound to assess stone mobility
DIFFERENTIAL DIAGNOSIS
Buy Membership for Radiology Category to continue reading. Learn more here